Emerging Agents in the Pipeline for Merkel Cell Carcinoma

2 Tampilan
administrator
administrator
07/17/23

Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.

  • Kategori

Menampilkan lebih banyak

0 Komentar Sortir dengan

Tidak ada komentar yang ditemukan

Komentar Facebook

Berikutnya